AN

Akansh Nainish Bora

Active Director Director DIN 10881224
DIN 10881224 First appointment Jan 2025 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 2 active board seats
Total affiliations 2 Since Jan 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Akansh Nainish Bora

Data last updated:

Akansh Nainish Bora is a Director at Clarovia Pharmaceuticals Private Limited (since 2025) and Designated Partner at Prl Medicor Llp (since 2025). The companies operate in Pharma.

DIN 10881224
Primary Designation Director
Industry Pharma
First Appointment 01 Jan 2025
Oldest Company Age 12 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director12 Aug 20252025Active
Prl Medicor Llp AAC-6402
Designated Partner01 Jan 20252014Active

Board colleagues of Akansh Nainish Bora

Directorship timeline

Open interactive timeline →
Clarovia Pharmaceuticals Private Limited
Prl Medicor Llp
Premium access

Shareholding and investment profile for Akansh Nainish Bora

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Akansh Nainish Bora

Akansh Nainish Bora currently holds 2 directorships: Clarovia Pharmaceuticals Private Limited (Director, since 12 Aug 2025); Prl Medicor Llp (Designated Partner, since 01 Jan 2025).

Akansh Nainish Bora was first appointed on 01 Jan 2025 as Designated Partner at Prl Medicor Llp.

The current boards of Akansh Nainish Bora's companies include Rishabh Nainish Bora (Clarovia Pharmaceuticals Private Limited), Sharad Mohanlal Bhatevara (Prl Medicor Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available